Z Selmeczy1, B Csóka, P Pacher, E S Vizi, G Haskó. 1. Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary. selmeczy@koki.hu
Abstract
OBJECTIVE: In this study we investigated the effect of CGS 21680 (2-p-(2-Carboxyethyl)phenethylamino-5-N-ethylcarboxamidoadenosine hydrochloride), an adenosine A2A receptor agonist, in a model of dextran sulphate sodium (DSS)-induced colitis. METHODS: NMRI mice were fed 5 % (w/v) DSS, and were treated intraperitoneally with 0.5 mg/kg CGS 21680 or vehicle for 10 days. Changes of bodyweight, colon length, the incidence of rectal bleeding, levels of macrophage inflammatory protein (MIP)-1alpha, MIP-2, interferon gamma, interleukin (IL)-1beta, IL-12 and tumour necrosis factor-alpha from homogenates of colon biopsies, and the release of [3H]acetylcholine (ACh) from longitudinal muscle strip were determined. RESULTS: DSS significantly decreased bodyweight, colon length, and it increased the incidence of rectal bleeding and levels of MIP-1alpha, MIP-2 and IL-1beta compared to DSS-untreated animals. CGS 21680 had no effect on these changes. No change could be observed in release of ACh in DSS-induced colitis with or without CGS 21680. CONCLUSION: In summary, CGS 21680 is ineffective in ameliorating DSS-induced colitis in mice.
OBJECTIVE: In this study we investigated the effect of CGS 21680 (2-p-(2-Carboxyethyl)phenethylamino-5-N-ethylcarboxamidoadenosine hydrochloride), an adenosine A2A receptor agonist, in a model of dextran sulphate sodium (DSS)-induced colitis. METHODS: NMRI mice were fed 5 % (w/v) DSS, and were treated intraperitoneally with 0.5 mg/kg CGS 21680 or vehicle for 10 days. Changes of bodyweight, colon length, the incidence of rectal bleeding, levels of macrophage inflammatory protein (MIP)-1alpha, MIP-2, interferon gamma, interleukin (IL)-1beta, IL-12 and tumour necrosis factor-alpha from homogenates of colon biopsies, and the release of [3H]acetylcholine (ACh) from longitudinal muscle strip were determined. RESULTS:DSS significantly decreased bodyweight, colon length, and it increased the incidence of rectal bleeding and levels of MIP-1alpha, MIP-2 and IL-1beta compared to DSS-untreated animals. CGS 21680 had no effect on these changes. No change could be observed in release of ACh in DSS-induced colitis with or without CGS 21680. CONCLUSION: In summary, CGS 21680 is ineffective in ameliorating DSS-induced colitis in mice.
Authors: S Gessi; K Varani; S Merighi; A Morelli; D Ferrari; E Leung; P G Baraldi; G Spalluto; P A Borea Journal: Br J Pharmacol Date: 2001-09 Impact factor: 8.739
Authors: G Haskó; D G Kuhel; J F Chen; M A Schwarzschild; E A Deitch; J G Mabley; A Marton; C Szabó Journal: FASEB J Date: 2000-10 Impact factor: 5.191
Authors: G Haskó; D G Kuhel; Z H Németh; J G Mabley; R F Stachlewitz; L Virág; Z Lohinai; G J Southan; A L Salzman; C Szabó Journal: J Immunol Date: 2000-01-15 Impact factor: 5.422
Authors: F Garcia Soriano; L Liaudet; A Marton; G Haskó; C Batista Lorigados; E A Deitch; C Szabó Journal: Crit Care Med Date: 2001-04 Impact factor: 7.598
Authors: L Liaudet; J G Mabley; F G Soriano; P Pacher; A Marton; G Haskó; C Szabó Journal: Am J Respir Crit Care Med Date: 2001-10-01 Impact factor: 21.405
Authors: J A McPherson; K G Barringhaus; G G Bishop; J M Sanders; J M Rieger; S E Hesselbacher; L W Gimple; E R Powers; T Macdonald; G Sullivan; J Linden; I J Sarembock Journal: Arterioscler Thromb Vasc Biol Date: 2001-05 Impact factor: 8.311
Authors: C M Aherne; B Saeedi; C B Collins; J C Masterson; E N McNamee; L Perrenoud; C R Rapp; V F Curtis; A Bayless; A Fletcher; L E Glover; C M Evans; P Jedlicka; G T Furuta; E F de Zoeten; S P Colgan; H K Eltzschig Journal: Mucosal Immunol Date: 2015-04-08 Impact factor: 7.313
Authors: Julia-Stefanie Frick; Christopher F MacManus; Melanie Scully; Louise E Glover; Holger K Eltzschig; Sean P Colgan Journal: J Immunol Date: 2009-04-15 Impact factor: 5.422
Authors: Margaret S Bynoe; Adam T Waickman; Deeqa A Mahamed; Cynthia Mueller; Jeffrey H Mills; Agnieszka Czopik Journal: J Biomed Biotechnol Date: 2012-10-14